Form 4: Sarepta Therapeutics Executive Louise Rodino-Klapac Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Louise Rodino-Klapac, Head of R&D and CSO at Sarepta Therapeutics, reports disposing of shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 7, 2024, Louise Rodino-Klapac, Head of R&D and CSO of Sarepta Therapeutics, disposed of 512 shares of common stock at a price of $120.49 to cover tax obligations.
- Following this transaction, Rodino-Klapac directly owns 68,982 shares of Sarepta Therapeutics common stock.
- On March 8, 2024, Rodino-Klapac disposed of 909 shares of common stock at a price of $123.14 to cover tax obligations.
- Following this transaction, Rodino-Klapac directly owns 68,073 shares of Sarepta Therapeutics common stock.
- The disposals were related to the vesting of restricted stock units granted on March 6, 2023, and March 7, 2022.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to tax obligations, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of restricted stock units grant related to the March 7, 2024 disposal. |
| 03/07/2022 | Date of restricted stock units grant related to the March 8, 2024 disposal. |
| 03/07/2024 | Date of disposal of 512 shares at $120.49. |
| 03/08/2024 | Date of disposal of 909 shares at $123.14. |
| 03/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.